产品编号 | 产品名称 | 产品包装 | 产品价格 |
L00151 | BRCA1基因敲除质粒 | 5µg | 999.00元 |
L00152 | BRCA1基因敲除慢病毒 | 10^8 TU | 6999.00元 |
L00153 | BRCA1基因敲除HEK293T细胞 | 1支/瓶 | 7999.00元 |
L00154 | BRCA1基因敲除HEK293T细胞RIPA裂解液 | 100µg | 1258.00元 |
L00155 | BRCA1基因敲除HEK293T细胞Trizol裂解液 | 500µl | 1258.00元 |
pLenti-BRCA1-sgRNA (BRCA1基因敲除质粒)是一种在动物细胞中可以同时表达Cas9、目的基因的sgRNA和puromycin抗性基因的质粒。用于在动物细胞中直接基于CRISPR/Cas9技术敲除目的基因,或者通过包装慢病毒后基于CRISPR/Cas9技术敲除目的基因。本质粒中sgRNA的有效性已经通过T7EI法的验证。
本质粒在细菌中为Amp抗性,全长约13,000bp。本质粒的关键图谱信息请参考图1。本质粒可直接转染细胞用于目的基因的CRISPR/Cas9敲除,以及通过puromycin筛选稳定细胞株;也可以与pMDLg、Rev及VSV-g共转HEK293T细胞进行重组慢病毒(lentivirus)的包装,然后再用于感染细胞或组织并进行目的基因的CRISPR/Cas9敲除。
图1. 表达sgRNA、Cas9和puromycin抗性的pLenti-sgRNA质粒关键图谱信息。
本质粒中的sgRNA基于碧云天研发的CRISPR/Cas9 sgRNA快速筛选和验证体系获得,sgRNA的有效性已经通过T7EI法验证。
本质粒用于实验时,建议同时选购无任何靶向的对照质粒pLenti-Control-sgRNA (L00011)或靶向GFP的对照质粒pLenti-GFP-sgRNA (L00013)。
碧云天同时提供基于CRISPR/Cas9技术的BRCA1基因敲除的质粒(L00151 pLenti-BRCA1-sgRNA)、慢病毒(L00152 BRCA1 Knockout Lentivirus)、HEK293T细胞(L00153 BRCA1 Knockout HEK293T Cells)、HEK293T敲除细胞的RIPA裂解液(L00154 BRCA1 Knockout HEK293T RIPA Lysate)、HEK293T敲除细胞的Trizol裂解液(L00155 BRCA1 Knockout HEK293T Trizol Lysate)等产品,具体请在碧云天网站查询或在本产品网页点击相应产品。
BRCA1基因的基本信息如下:
Species | Gene Symbol | Gene ID | GenBank Accession | Transcript |
Human | BRCA1 | 672 | BC072418 | NM_007294 |
About the gene | |
Official Symbol | BRCA1 |
Previous Symbol | - |
Official Full Name | BRCA1, DNA repair associated |
Synonyms | RNF53; BRCC1; PPP1R53; FANCS |
Location | 17q21.31 |
Gene Type | protein-coding gene |
Uniprot ID | P38398 |
Pathway/Library | cAMP & Ca Signaling Pathway Related Genes Library; Ubiquitin Ligases Genes Library |
Gene Summary | This gene encodes a nuclear phosphoprotein that plays a role in maintaining genomic stability, and it also acts as a tumor suppressor. The encoded protein combines with other tumor suppressors, DNA damage sensors, and signal transducers to form a large multi-subunit protein complex known as the BRCA1-associated genome surveillance complex (BASC). This gene product associates with RNA polymerase II, and through the C-terminal domain, also interacts with histone deacetylase complexes. This protein thus plays a role in transcription, DNA repair of double-stranded breaks, and recombination. Mutations in this gene are responsible for approximately 40% of inherited breast cancers and more than 80% of inherited breast and ovarian cancers. Alternative splicing plays a role in modulating the subcellular localization and physiological function of this gene. Many alternatively spliced transcript variants, some of which are disease-associated mutations, have been described for this gene, but the full-length natures of only some of these variants has been described. A related pseudogene, which is also located on chromosome 17, has been identified. |
产品编号 | 产品名称 | 包装 |
L00151 | pLenti-BRCA1-sgRNA | 5µg |
— | 说明书 | 1份 |
-20℃保存,至少两年有效。
注意事项:碧云天拥有sgRNA序列的知识产权,如果需要sgRNA序列,请在订购后发送邮件向info@beyotime.com索取。sgRNA与质粒及其序列信息,未经碧云天书面许可不得用于任何商业用途,也不得移交给订货人所在实验室外的任何个人或单位。使用者在发表研究论文或结果时,应注明来源。
慢病毒包装使用的包装质粒,可以订购碧云天的Lentivirus Packaging Vectors Set A (L00002),包括pMDLg、Rev和VSV-g。
对于非目录产品的CRISPR基因敲除用的sgRNA表达质粒的定制,可联系碧云天技术服务service@beyotime.com。
本产品仅限于专业人员的科学研究用,不得用于临床诊断或治疗,不得用于食品或药品,不得存放于普通住宅内。
为了您的安全和健康,请穿实验服并戴一次性手套操作。